NCT02093546View on ClinicalTrials.gov

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 13, 2004

Primary Completion Date

January 15, 2020

Study Completion Date

January 15, 2020

Conditions
Recurrent Endometrial Carcinoma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood and tumor

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02093546 - Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 | Biotech Hunter | Biotech Hunter